NDRA - ENDRA Life Sciences Inc.
6.01
0.026 0.429%
Share volume: 26,437
Last Updated: 05-07-2025
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.02%
PREVIOUS CLOSE
CHG
CHG%
$5.98
0.03
0.00%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-14-2024 | 08-14-2023 | 11-14-2023 | 11-21-2024 | 05-14-2024 | 08-14-2024 | 11-21-2024 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| nan% | nan% | nan% | nan% | nan% | ||||
| Operating expenses | 2.761 M | 2.747 M | 2.886 M | 1.307 M | 2.547 M | 2.068 M | 1.426 M | |
| Selling general and admin | 1.370 M | 1.347 M | 1.253 M | 727.179 K | 1.505 M | 1.352 M | 631.413 K | |
| Research and development | 1.391 M | 1.400 M | 1.633 M | 579.350 K | 1.042 M | 716.366 K | 794.444 K | |
| Total expenses | 2.943 M | 2.995 M | 3.129 M | 1.454 M | 2.785 M | 2.231 M | 1.509 M | |
| 1.76% | 4.49% | -53.52% | 91.52% | -19.91% | -32.36% | |||
| Operating income | -2.939 M | -2.995 M | -3.129 M | -1.458 M | -2.781 M | -2.231 M | -1.509 M | |
| Ebit | -2.936 M | -2.557 M | -3.157 M | -1.466 M | -2.785 M | -2.229 M | -4.916 M | |
| Pretax income | -2.943 M | -2.557 M | -3.101 M | -1.460 M | -2.776 M | -2.229 M | -2.354 M | |
| -13.10% | 21.26% | -52.93% | 90.18% | -19.69% | 5.60% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -2.943 M | -2.557 M | -3.101 M | -1.460 M | -2.776 M | -2.229 M | -2.354 M | |
| 13.10% | -21.26% | 52.93% | -90.18% | 19.69% | -5.60% |
